95 related articles for article (PubMed ID: 19286253)
41. Molecular pathogenesis of tuber formation in tuberous sclerosis complex.
Crino PB
J Child Neurol; 2004 Sep; 19(9):716-25. PubMed ID: 15563019
[TBL] [Abstract][Full Text] [Related]
42. Applying the Lessons of Tuberous Sclerosis: The 2015 Hower Award Lecture.
Roach ES
Pediatr Neurol; 2016 Oct; 63():6-22. PubMed ID: 27543366
[TBL] [Abstract][Full Text] [Related]
43. Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.
Finlay GA; Thannickal VJ; Fanburg BL; Kwiatkowski DJ
Cancer Res; 2005 Dec; 65(23):10881-90. PubMed ID: 16322235
[TBL] [Abstract][Full Text] [Related]
44. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.
Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818
[TBL] [Abstract][Full Text] [Related]
45. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
[TBL] [Abstract][Full Text] [Related]
46. Tuberin--a new molecular target in Alzheimer's disease?
Ferrando-Miguel R; Rosner M; Freilinger A; Lubec G; Hengstschläger M
Neurochem Res; 2005 Nov; 30(11):1413-9. PubMed ID: 16341938
[TBL] [Abstract][Full Text] [Related]
47. Hamartin variants that are frequent in focal dysplasias and cortical tubers have reduced tuberin binding and aberrant subcellular distribution in vitro.
Lugnier C; Majores M; Fassunke J; Pernhorst K; Niehusmann P; Simon M; Nellist M; Schoch S; Becker A
J Neuropathol Exp Neurol; 2009 Oct; 68(10):1136-46. PubMed ID: 19918125
[TBL] [Abstract][Full Text] [Related]
48. The tuberous sclerosis complex proteins--a GRIPP on cognition and neurodevelopment.
de Vries PJ; Howe CJ
Trends Mol Med; 2007 Aug; 13(8):319-26. PubMed ID: 17632034
[TBL] [Abstract][Full Text] [Related]
49. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression.
Soucek T; Rosner M; Miloloza A; Kubista M; Cheadle JP; Sampson JR; Hengstschläger M
Oncogene; 2001 Aug; 20(35):4904-9. PubMed ID: 11521203
[TBL] [Abstract][Full Text] [Related]
50. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
[TBL] [Abstract][Full Text] [Related]
51. Brain lesions in tuberous sclerosis complex. Review.
Grajkowska W; Kotulska K; Jurkiewicz E; Matyja E
Folia Neuropathol; 2010; 48(3):139-49. PubMed ID: 20924998
[TBL] [Abstract][Full Text] [Related]
52. Insulinoma and Tuberous Sclerosis: A Possible Mechanistic Target of Rapamycin (mTOR) Pathway Abnormality?
Kang MY; Yeoh J; Pondicherry A; Rahman H; Dissanayake A
J Endocr Soc; 2017 Sep; 1(9):1120-1123. PubMed ID: 29264566
[TBL] [Abstract][Full Text] [Related]
53. Beyond Protein Synthesis; The Multifaceted Roles of Tuberin in Cell Cycle Regulation.
Fidalgo da Silva E; Fong J; Roye-Azar A; Nadi A; Drouillard C; Pillon A; Porter LA
Front Cell Dev Biol; 2021; 9():806521. PubMed ID: 35096832
[TBL] [Abstract][Full Text] [Related]
54. Hamartin: An Endogenous Neuroprotective Molecule Induced by Hypoxic Preconditioning.
Li S; Ren C; Stone C; Chandra A; Xu J; Li N; Han C; Ding Y; Ji X; Shao G
Front Genet; 2020; 11():582368. PubMed ID: 33193709
[TBL] [Abstract][Full Text] [Related]
55. Multiple pulmonary artery aneurysms in tuberous sclerosis complex.
Dunet V; Qanadli SD; Lazor R; Beigelman-Aubry C
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23341583
[TBL] [Abstract][Full Text] [Related]
56. New insights into the role of the tuberous sclerosis genes in leukemia.
Rosner M; Fuchs C; Siegel N; Valli A; Hengstschläger M
Leuk Res; 2009 Jul; 33(7):883-5. PubMed ID: 19286253
[TBL] [Abstract][Full Text] [Related]
57. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.
Rosner M; Freilinger A; Hengstschläger M
Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332
[TBL] [Abstract][Full Text] [Related]
58. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
[TBL] [Abstract][Full Text] [Related]
59. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer.
Kataoka K; Fujimoto K; Ito D; Koizumi M; Toyoda E; Mori T; Kami K; Doi R
Surgery; 2005 Sep; 138(3):450-5. PubMed ID: 16213898
[TBL] [Abstract][Full Text] [Related]
60. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA
Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
